DAX25.005 +0,8%Est506.022 +0,7%MSCI World4.343 -0,1%Top 10 Crypto8,7500 +0,2%Nas22.523 -0,1%Bitcoin57.414 -1,3%Euro1,1834 -0,1%Öl67,19 -2,0%Gold4.879 -2,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 SAP 716460 Siemens 723610 Deutsche Telekom 555750 Siemens Energy ENER6Y Bayer BAY001 NVIDIA 918422 Amazon 906866 Lufthansa 823212 Microsoft 870747 DroneShield A2DMAA BASF BASF11 RENK RENK73 Mercedes-Benz Group (ex Daimler) 710000 Deutsche Bank 514000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX schließt stärker -- Novo Nordisk setzt Aktienrückkauf fort -- Rheinmetall mit Großauftrag -- Steyr, Microsoft, TeamViewer, Norwegian, BHP, Ottobock, Warner Bros. im Fokus
Top News
Zebra Technologies - Digitalisierungs-Profiteur dank anziehender Konsumnachfrage weiter auf Wachstumskurs! Zebra Technologies - Digitalisierungs-Profiteur dank anziehender Konsumnachfrage weiter auf Wachstumskurs!
Investieren in KI-Aktien Investieren in KI-Aktien
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Eli Lilly Aktie

Kaufen
Verkaufen
Eli Lilly Aktien-Sparplan
880,10 EUR -0,20 EUR -0,02 %
STU
1.041,06 USD +0,61 USD +0,06 %
BTT
Eli Lilly jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.828,20 Mrd. EUR

KGV46,82Div. Rendite0,56%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN858560

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS5324571083

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolLLY

Eli Lilly Aktien News

DatumMeistgelesen
BenzingaEli Lilly Co. Q2 FY2025 Earnings Transcript
BenzingaApple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday?
ZacksHere's Why Eli Lilly (LLY) is a Strong Growth Stock
MotleyFoolEli Lilly (LLY) Q2 Revenue Jumps 38%
Financial TimesEli Lilly obesity pill disappoints and gives boost to arch-rival Novo Nordisk
ZacksEli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates
EN, Eli LillyLilly reports second-quarter 2025 financial results and raises guidance
PR NewswireLilly reports second-quarter 2025 financial results and raises guidance
New York TimesPill Causes Major Weight Loss in Eli Lilly Trial’s Results
PR NewswireLilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity
EN, Eli LillyLilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity
BenzingaStock Market Today: US Futures Rise Amid Russia Peace Talk Update—Investors Await Eli Lilly, Block Earnings (UPDATED)
BenzingaEli Lilly, ConocoPhillips And 3 Stocks To Watch Heading Into Thursday
BenzingaRFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
BenzingaHow To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings
BenzingaEli Lilly Reverses Early Weakness, Closes Near Day's High After Key Trading Signal
BenzingaSpotlight on Eli Lilly: Analyzing the Surge in Options Activity
MotleyFoolWhy Eli Lilly Stock Topped the Market Today
ZacksEli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
BenzingaEli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health
PR NewswireLilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart ...
PR NewswireLilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease
EN, Eli LillyLilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease
MotleyFoolWhy Eli Lilly Stock Was Looking Sickly Today
ZacksEli Lilly (LLY) Declines More Than Market: Some Information for Investors
BenzingaWhat's Going On With Eli Lilly Stock On Tuesday?
BenzingaEli Lilly Options Trading: A Deep Dive into Market Sentiment
EN, Eli LillyLilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL
PR NewswireLilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, met its primary endpoint in a head-to-head Phase 3 trial versus Imbruvica (ibrutinib) in CLL/SLL
ZacksEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
PR NewswireLilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
EN, Eli LillyLilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
PR NewswireDonanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer's disease
EN, Eli LillyDonanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer's disease
MotleyFoolThe 3 Things That Matter for Eli Lilly Now
PR NewswireLilly confirms date and conference call for second-quarter 2025 financial results announcement
EN, Eli LillyLilly confirms date and conference call for second-quarter 2025 financial results announcement
PR NewswireLilly and Verve announce expiration of Verve tender offer
EN, Eli LillyLilly and Verve announce expiration of Verve tender offer
ZacksWhy Eli Lilly (LLY) is a Top Growth Stock for the Long-Term

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.